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6/j.bAnimal and human studies have shown that after allogeneic hematopoietic cell transplantation, epithelial cells
containing donor-derived genome emerge. The mechanisms underlying this phenomenon are still unclear.
We hypothesized that horizontal transfer of the hematopoietic donor-DNA to the host epithelium confers
a possible operating mechanism. In an in vitro model mimicking the lymphocyte–epithelial interaction, we
cocultivated keratinocyte HaCaT cells (Y-chromosome negative) with nonapoptotic or apoptotic, CMFDA,
or BrdU-labeled hematopoietic Jurkat cells (Y1) and looked for the emergence of HaCaT cells bearing Jurkat
genome. We found that DNA can be horizontally transferred from hematopoietic to epithelial cell lines
through phagocytosis of apoptotic bodies. The ingested genomic material was also found within the nuclear
compartment and in isolated chromosomes obtained from HaCaT metaphases. Both lysosomal inhibition in
HaCaT cells and repetitive load of HaCaT cells with apoptotic bodies increased the intercellular and intra-
nuclear DNA delivery. Although recipient cells remained viable and showed to express the foreign DNA, this
expression was transient. Taking into consideration these findings of horizontal DNA transfer between he-
matopoietic and epithelial cells, we evaluated by quantitative microsatellite analysis the amount of donor
DNA in 176 buccal swabs obtained from 71 patients after allogeneic transplantation.We found a high amount
of donor-DNA (mean 26.6%) in the majority (89.7%) of them, although no donor hematopoietic cells were
evident in the samples by immunofluorescence. We propose that the incessant charge of the transplant re-
cipient with donor-DNA and its ‘‘inappropriate’’ intranuclear delivery in host epithelium may explain the
emergence of epithelial cells with donor-derived genome.
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Apoptotic bodiesINTRODUCTION
Allogeneic hematopoietic cell transplantation (allo-
HCT) has become a standard treatment for many
hematologic malignancies. During allo-HCT, the
recipient receives a preparative conditioning regimenartment of Hematology/Oncology Albert Ludwigs
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bmt.2010.09.001(eg, chemotherapy, radiotherapy) to destroy his
hematopoiesis and immune system. This practice is
followed by the administration of hematopoietic
stem cells harvested from the donor, which engraft,
proliferate, and finally reconstitute hematopoiesis in
the recipient [1]. Although allo-HCT has been a part
of clinical practice for more than 30 years, recent stud-
ies revealed hidden consequences of the coexistence of
2 genetically distinct populations in the transplant re-
cipient. There is now accumulating evidence of the
generation of a low percentage of epithelial cells
containing donor-derived genome, a phenomenon
that was initially misinterpreted as ‘‘stem cell plastic-
ity’’[2-6]. Chimerism in epithelium after allo-HCT
has been previously shown in animal models and in
humans by in situ detection of Y-chromosome in fe-
male recipients [3-7]. Despite the initial skepticism
of the reported observations because of methodologic
limitations, more recent studies using strict criteria
and examinations of isolated single cells have clearly
shown that following allogeneic HCT in humans,319
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emerge [5,7]. The mechanisms underlying this
phenomenon are unclear and divergent. Suggested
mechanisms attempting to explain epithelial chimeric
events after allo-HCT include transdifferentiation of he-
matopoietic cells into epithelial cells, generation of epi-
thelial cells from unknown epithelial precursors and/or
universal stem cells in the graft, and fusion of donor he-
matopoietic cells with recipient epithelial cells [8-10].
Production of donor cells from the engrafted bone
marrow is an ongoing process in the allo-transplanted
recipient. Apoptosis is a well-recognized source of
DNA in several clinical settings, such as cancer, exten-
sive burning, graft-versus-host disease (GVHD), and
transplantation. Donor cells undergoing apoptosis re-
lease donor-DNA packaged into apoptotic bodies [11].
Although foreign DNA is normally cleared up [12,13],
the fate of the large amount of released donor-derived
genetic material in the transplant recipient is un-
known. Horizontal gene transfer (HGT) is a phenom-
enon in which DNA from one cell (donor cell) is
transferred, incorporated, and sometimes expressed
by another recipient cell. The horizontal transfer of
genetic material is well described in prokaryotic
organisms as a means for fast adaption to changing
environmental conditions and also as an evolutionary
mechanism [14]. In eukaryotic organisms, HGT has
been assumed to be of limited significance; however,
there is a growing awareness that genetic material
may be horizontally transferred between cells in differ-
ent clinical settings such as inflammation, cancer, and
after tissue or organ transplantation [15-19].
We here hypothesized that transfer and incorpora-
tion of circulating genomic material from donor-
hematopoietic to host-epithelial cells occurs after
allo-HCT andmay explain the emergence of epithelial
cells with donor-derived genome. Therefore, in an in
vitro model mimicking the lymphocyte-epithelial in-
teraction, we asked whether apoptotic material from
hematopoietic Jurkat cells may mechanistically confer
to the emergence of HaCaT epithelial cells bearing
donor genome. Furthermore, we evaluated the amount
donor-derivedDNA in buccal epithelium of allogeneic
transplanted patients.MATERIALS AND METHODS
Cell Lines and Apoptosis Induction
The human nontumorigenic keratinocyte cell line
HaCaT (German Cancer Research Center, Heidel-
berg, Germany), the Human T Cell Leukemia Jurkat
cell line, and the transfectedwith the pOSGFPplasmid
(GFP expressing-GFP1) Human T Cell Leukemia
JvM-13 cell line were maintained in DMEM (GIBCO,
BRL, Germany) or RPMI medium (GIBCO) supple-
mented with 10% FBS (GIBCO) and antibiotics.Bone marrow from healthy female donors (obtained
under University of Freiburg Institutional Review
Board Protocol) were cultivated in NH Expansion
Medium, without serum (MACS Miltenyi Biotec,
Germany). The adherent fraction of these cells was
used for the experiments. Cells were incubated at
37C in 5% CO2 humidified cell culture incubator.
Apoptosis was induced in Jurkat and JvM-13 cells by
treatment with DNA topoisomerase I inhibitor camp-
tothecin (Sigma, St. Louis, MO,USA) at a final dose of
4 mM for up to 12 hours. Apoptosis was detected by the
morphology of apoptotic nuclei after Hoescht 33242
(Sigma) staining and by DNA ladder assay, and the
percentage of apoptotic cells was assessed by FACS
with Annexin-V/PI staining (BD Pharmingen, San
Diego, CA, USA) or antiactivated-caspace antibody
(CaspACE FITC-VAD-FMK, Promega, Madison,
WI, USA).In Vitro Cocultivation Assay and Analysis
HaCaT cells reached approximately 60% of con-
fluency and then were cocultivated with either apopto-
tic or intact Jurkat cells or GFP1JvM-13 cells in
a proportion 4:1 for 24-72 hours. Jurkat cells were
previously labeled with the cell tracker CMFDA (Mo-
lecular Probes, Heidelberg, Germany) or with the thy-
midine analog BrdU (Roche, Mannheim, Germany)
according to manufacturer’s instructions. Cocultiva-
tion experiments were also performed in a transwell
system (0.4-mmpores) or after pretreatment of HaCaT
cells with cytochalasin B (4 mM) or bafilomycin
(50 nM) (Sigma). Each drug was incorporated in the
culture medium 1-2 hours before cocultivation and
thereafter throughout the cocultivation period. In
some experiments, the HaCaT cultures were repeti-
tively challenged with Jurkat apoptotic or nonapop-
totic cells by removing every 12 hours the
supernatant, washing the adherent cells, and adding
fresh Jurkat apoptotic or nonapoptotic cells. In other
experiments, apoptotic bodies from JvM-13 cells
were preincubated with DNase I (Invitrogen, Ger-
many) for 1 hour at 37C before cocultivation with
HaCaT cells. After cocultivation, HaCaT cells were
harvested by trypsinization, washed, and placed in mi-
croscope slides by cytocentrifugation. Cells were fixed
in methanol:acetone (3:1) at 220C for 10 minutes.
Slides were stained with anti-BrdUmouse monoclonal
antibody (BMG6H8 IgG1;Roche) followed by a sheep
anti-mouse Ig-fluorescein (Roche) or a goat anti-
mouse IgG Alexa 633 (H1L; Invitrogen) antibody,
monoclonal mouse anti-human-CD45 antibody
(2B111PD 7126, DAKO, Glostrup, Denmark), fol-
lowed by a goat anti-mouse IgG Alexa 647 (H1L, In-
vitrogen) secondary antibody, antiphospho histone
H2AX (clone JBW301, Millipore, Bedford, MA,
USA), monoclonal antipancytokeratin FITC conjugate
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indole, Sigma) nuclear counterstain, and Y- and
X-chromosome–specific fluorescence in situ hybrid-
ization (FISH) probes (Vysis, Bergisch-Gladbach,
Germany). Negative controls included omission of
the Y probe in FISH, use of isotype-matched control
antibodies for BrdU staining and staining of HaCaT
cells (CD45 negative and Y chromosome negative
tested either by FISH or by PCR for the SRY gene).
Slides of Jurkat cells were used as positive controls
for FISH-Y analysis and CD45 staining (100% Y1
and CD45%). At least 200 cells were analyzed by laser
scanning confocal microscopy (TCS/SP2/AOBS Le-
ica Microsystems, Heidelberg, Germany). Serial con-
focal images were reconstructed in 3 dimensions
using specialized commercial software (Autovisualize
5.5, AutoQuant Imaging, Troy, NY, USA). HaCaT
cells were negative for Y chromosome tested either
by FISH or by PCR for the SRY gene, whereas Jurkat
cells were positive for Y chromosome using the same
methodology. After coculture with GFP1JvM-13
cells, HaCaT cells (CD45 negative gate) were as-
sessed for GFP by fluorescence activated cell sorter
(FACS) analysis and fluorescence microscopy.
Metaphase Spreads
After cocultivation, HaCaT cells were washed and
incubated with 150 ng/mL colcemid (GIBCO) for 2
hours. The cells were then harvested, incubated in
hypotonic solution (75 mM KCl) for 1 hour at room
temperature, fixed with a 3:1 methanol:acetic acid so-
lution overnight, and finally dropped onto slides.
The obtained metaphases were hybridized with a fluo-
rescent probe for Y-chromosome (Vysis) or stained
with a mouse anti-BrdU FITC-labeled antibody
(Roche), counterstained with DAPI, and analyzed
with laser scanning confocal microscope (Leica) and
3D analysis. Negative controls included omission of
the Y probe in FISH, parallel FISH-Y of HaCaT cells
(Y-negative) and use of isotype-matched control anti-
bodies for BrdU staining (mouse IgG1, BD Pharmin-
gen). At least 20 metaphases were analyzed. Slides
without hypotonic treatment were done in parallel
and stained with CD45 in order to exclude contami-
nating Jurkat cells.
Cell Sorting
After cocultivation of HaCaT cells with BrdU-
labeled apoptotic bodies derived from Jurkat cells,
BrdU positive (BrdU1) and BrdU negative (BrdU2)
HaCaT cells were isolated in a Mo-Flo cell sorter
(Cytomation, Ft. Collins, CO, USA). Briefly, cells
were stained with anti-CD45-PE (BD Pharmingen),
anti-BrdU mouse monoclonal antibody (BMG 6H8
IgG1; Roche), followed by a sheep antimouse Ig-
fluorescein secondary antibody (Roche) and a 2-logdifference in fluorescence intensity was used in order
to define the BrdU1 from the BrdU population. Sort-
ing efficiency was checked by fluorescence micros-
copy. Apoptosis was determined by flow cytometry
in both populations labeling the cells with Annexin V
(BD Pharmingen).
Subjects and Sample Collection
Patients who underwent allogeneic HCT partici-
pated in the institutional review board–approved study
after informed consent. Patient selection was based on
the absence of clinical signs of mucositis at the time of
buccal sampling. Buccal smear sampling was per-
formed by softly brushing the mucosal cheek with
a new nylon-bristle toothbrush (Omnibrush, Omni-
dent, Rodgau, Germany), as previously described [5].
Buccal smears and blood were also obtained from con-
trol healthy individuals after informed consent. Cyto-
spins of buccal samples were stained with hematoxylin/
eosin (HE) and with hematopoietic cell and Langer-
han’s specific antibodies by immunohistochemistry
or immunofluorescence, as previously described [5,6].
The following primary mouse anti-human antibodies
were used: CD45 (2B111 PD7/26; DAKO, Glostrup,
Denmark), CD3 (SK7; Beckton-Dickinson, Franklin
Lake, NJ, USA), CD15 (MMA; Beckton-Dickinson),
CD68 (PG-M1; DAKO), Langerin (V-14; Santa
Cruz Biotechnology, Santa Cruz, CA, USA). Mixed
samples of buccal epithelial cells and peripheral lym-
phocytes or samples from patients with severe mucosi-
tis were used as positive controls of the assay. At
least 200 cells/slide were analyzed. In addition, in
order to exclude the presence of hematopoietic cells
within the bucall samples, buccal cell suspensions
were stained with anti-CD45-PE (BD Pharmingen
Heidelberg, Germany) and antipancytokeratin FITC
conjugate (clone C-11; Sigma) antibodies and analyzed
by FACS.
Microsatellite Analysis
DNA was extracted by QIAamp DNA Micro Kit
(Qiagen, Hilden, Germany). Microsatellite analysis
was performed by singleplex PCR for THO-1, SE33,
D14S120, and D1S80 markers and analysis of the
fragment sizes of the PCR products by capillary elec-
trophoresis (ABI Prism 310 Genetic Analyzer and
GeneScan software, Applied Biosystems, Weiterstadt,
Germany), as described [20]. Chimerism analyses of
a microsatellite marker was determined and quantified
based on the ratio of informative donor and recipient
peak areas, as previously described in detail [20].
Statistics
Unpaired Student’s t-test or Mann-Whitney test
was used according to the nature of the data. P\ .05
was considered significant.
Figure 1. Apoptotic bodies can transfer DNA to cultured epithelial cells and primary BMSC. (A) Percentage of CMFDA, BrdU, or FISH-Y chromosome
signals in HaCaT cells after their cocultivation for 24-72 hours with apoptotic or nonapoptotic Jurkat cells (Y1, BrdU, and/or CMFDA labeled). A rep-
resentative example of a HaCaT cell with engulfed CMFDA1 apoptotic bodies is shown. (B) Detection of BrdU and FISH-Y signals within the nucleus of
HaCaT cells analyzed by confocal microscopy and 3D analysis. (C) Image shows a prophase of a dividing HaCaT cell stained positive for FISH-Y (above).
BrdU and FISH-Y signals were found within the isolated chromosomes in metaphase spreads from HaCaT cells (below). (D) Detection of BrdU and
FISH-Y signals within the nucleus of primary BMSC analysed by confocal microscopy and 3D analysis. CK: cytokeratin, DAPI: nuclear stain. Data in graphs
are represented as mean 1 SD. Magnification 600.
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Apoptotic Bodies Can Transfer DNA to
Epithelial Cells In Vitro
We evaluated whether keratinocyte HaCaT cells
(Y-chromosome negative) may acquire foreign DNA
after their cocultivation with intact Jurkat lymphatic
cells (Y-chromosome positive) or apoptotic bodies
derived from Jurkat cells. Apoptosis was reproduciblyinduced by Camptothecin in Jurkat cells that were
previously labeled with CMFDA (cell tracker) or
BrdU (Supplemental Figure S1). After cocultivation
and before further staining, we washed the cultures
several times in order to remove all nonadherent
Jurkat cells or Jurkat apoptotic bodies, and only the
adherent epithelial cells were used for the cytospins.
HaCaT cells cocultivated with intact, nonapoptotic
Jurkat cells for 24-72 hours did not show any CMFDA,
Figure 2. Mechanisms of DNA transfer. Percentage of HaCaT cells
with intracellular or intranuclear BrdU1 signal after their coculture
for 48 hours with BrdU-labeled apoptotic bodies, apoptotic bodies
separated from the HaCaT cells in a transwell system (T/W), or after
pretreatment with cytochalasin or bafilomycin. Repeated exposure indi-
cates that HaCaT cells were challenged with apoptotic bodies that were
replaced every 12 hours (4 challenges). Data in graphs are represented
as mean 1 SD.
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Figure 1A). In contrast, cocultivation of HaCaT cells
with Jurkat-derived apoptotic bodies for the same pe-
riod of time resulted in engulfment of apoptotic mate-
rial and Jurkat DNA in the HaCaT cells, as shown by
the detection of CMFDA signal in 28% of the HaCaT
cells, BrdU signal in about 18%, and FISH-Y signal in
about 3% of the cells (Figure 1A). The uptake of
apoptotic DNA reached a peak after 48 hours of cocul-
tivation and declined later (Figure 1A). It must be no-
ticed that all cells with engulfed apoptotic bodies were
indeed HaCaT cells because they revealed a clear epi-
thelial morphology and were stained positive for cyto-
keratine (CK1). Furthermore, slides were also stained
with CD45 antibodies, and we never found CD451
contaminating Jurkat cells. Coculture in a transwell
system resulted in no transference of donor BrdU-
labelled material in the HaCaT cells (Figure 2).
Therefore, BrdU labeling in HaCaT cells was because
of Jurkat DNA transfer and not because of traces of
extracellular BrdU remaining in the cell suspension.
We furthermore examined whether the DNA from
the Jurkat-derived apoptotic bodies was transferred
not only in the cytoplasm, but also into the nuclei of
the recipient cells. Confocal microscopy and 3D anal-
ysis confirmed that after 48 hours cocultivation, the in-
gested BrdU1 and Y1 genomic material was not only
present in the cytoplasm, but was also transferred into
the nuclear compartment of 4% and 0.6% of HaCaT
cells, respectively (Figure 1B). Again, all examined
BrdU1 and Y1 cells were CK1, revealed an epithelial
morphology, and no CD45-positive cells weredetected, excluding the possibility that the detected
Y1 cells were contaminating nonapoptotic Jurkat
cells. Interestingly, FISH-Y signal was also found in
different stages of HaCaT cell mitosis (Figure 1C).
In order to test whether the transferred apoptotic
DNA followed the fate of the chromosomes during
mitosis, we obtained metaphase spreads of HaCaT
cells charged for 48 hours with Jurkat apoptotic bodies
and stained the isolated chromosomes with DAPI and
a probe specific for Y chromosome or with an anti-
BrdU antibody. Negative controls included omission
of the Y probe in FISH, parallel FISH-Y of metaphase
spreads of HaCaT cells (Y-negative), and use of
isotype-matched control antibodies for BrdU staining.
Importantly, all analyzed metaphases were derived
from HaCaT cells because slides without hypotonic
treatment made in parallel and stained for CD45,
revealed no contaminating Jurkat cells by immunoflu-
orescence. Interestingly, 2% of themetaphases showed
a BrdU signal in several chromosomes, suggesting the
creation of hybrid chromosomes (Figure 1C). In 0.5%
of themetaphases, it was possible to observe a unique Y
signal within the rest of the chromosomes (Figure 1C).Apoptosis-Mediated Horizontal DNA
Transfer into Primary Bone Marrow
Stromal Cells In Vitro
We have also tested whether apoptotic DNA can
be horizontally transferred with similar efficiency to
human primary cells.We therefore performed coculti-
vation experiments with the adherent fraction of bone
marrow cultures (BM stromal cells [BMSC]) as recip-
ient cells. Similar to experiments with epithelial cell
lines, BMSC cocultivated with intact, nonapoptotic
Jurkat cells for 48 hours did not show any CMFDA
or BrdU signals. In contrast, BMSCs showed a high
percentage of CMFDA1 (25%) and BrdU1 (21%)
cells after 48 hours of cocultivation with labeled
Jurkat-derived apoptotic bodies. The ingested BrdU1
genomic material was not only present in the cyto-
plasm, but was also detected within the nucleus of
5% of the stromal cells (Figure 1D).Mechanisms of DNATransfer
After coculture of HaCaT cells and primary
BMSC cells with apoptotic bodies in a transwell sys-
tem, no donor BrdU-labeled material or Y chromo-
some was detected in the cytoplasm or in the nucleus
of both cell types, suggesting that transfer of free
DNA is not operable in this system and a close contact
between cells and apoptotic bodies is needed for hori-
zontal DNA transfer (Figure 2). Indeed, the horizontal
transfer of foreign DNA into the host genome in our
system was mediated through active phagocytosis of
the apoptotic bodies. When HaCaT cells were
Figure 3. HaCaT cells bearing foreign DNAmay express the transferred genome. (A) HaCaT cells were cocultured with apoptotic GFP1JvM-13 cells,
nonapoptotic GFP1JvM-13, apoptotic GFP1JvM-13 in a transwell system (T/W), or with apoptotic GFP1JvM-13 pretreated with DNaseI. After co-
cultivation, cultures were washed several times in order to remove all nonadherent JvM-13 cells or JvM-13 apoptotic bodies, and only the adherent
HaCaT cells were used for further analysis. GFP expression was evaluated by FACS in terms of fluorescence intensity compared to untreated cells.
(B) GFP expression in HaCaT cells was also evaluated by fluorescence microscopy, and representative photos are shown (DAPI:blue, GFP:green).
Magnification 600.
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tosis, the uptake of Jurkat-derived apoptotic bodies or
DNA was obstructed (Figure 2). Normally, internal-
ized foreign material is degradated in the cytoplasm
by lysosomes. Inhibition of the lysosomal activity by
bafilomycin increased the intracellular engulfment
and nuclear incorporation of the BrdU-labeled DNA
within HaCaT cells 3-fold and 2.5-fold (48-hour
time point), respectively (Figure 2). After 72-hour co-
culture no BrdU signal was evident. However, when
HaCaT cells were repetitively challenged with Jurkat
apoptotic bodies that were replaced every 12 hoursfor a period of 48 hours (4  challenged), the number
of HaCaT cells with intracellular and intranuclear
BrdU increased 1.5- and 2-fold, respectively, at the
48-hour time point (Figure 2).Transferred DNA Is Transiently Expressed and
Not Propagated
We asked whether genomic material transferred
through apoptotic bodies could be expressed in the re-
cipient cells. Cocultivation of HaCaT cells with apo-
ptotic bodies derived from GFP1 JvM-13 cells,
Figure 4. HaCaT cells bearing foreignDNA are viable and able to proliferate. (A) HaCaT cells were coculturedwith BrdU-labeled apoptotic Jurkat cells
and then BrdU1 and BrdU2 populations were isolated by FACS sorting, assessed by FACS for percentage of Annexin1 apoptotic cells and by micro-
satellite analysis for the presence of foreign DNA, and then placed in culture. After 1 week in culture, BrdU1 sorted cells reached similar confluency as
the BrdU2 fraction. No BrdU or Y signal was any more detectable in the BrdU1 sorted population after 1 week of culture. CK: cytokeratin, DAPI:
nuclear stain. Stain colors as indicated by the legends. Magnification 100.
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detection threshold at the 72-hour time point
(Figure 3). The mean fluorescence intensity increment
was transient and after 96 hours of cocultivation no
further fluorescence increase was detected. When
HaCaT cells were cocultured with nonapoptotic
GFP1 JvM-13 cells, with GFP1 JvM-13–derived
apoptotic bodies separated from the HaCaT cells in
a transwell system, or with GFP1 apoptotic bodies
pretreated with DNase I, no GFP fluorescence
increase was observed (Figure 3). Thus, the GFP
positivity in theHaCaT cells was because of expression
of the ingested foreign DNA and not because of GFP-
protein or GFP-RNA transfer.
We chargedHaCaT cells with BrdU-labeled Jurkat
apoptotic bodies and isolated by FACS-sorting both the
BrdU1 and BrdU2 adherent HaCaT cells. The purity
of both sorted populations was confirmed by fluores-
cence microscopy after anti-BrdU stain and showed
.98% BrdU signal in the positive sorted cells and no
BrdU signal in the negative fraction. In addition, all
BrdU1 sorted cells stained positive for cytokeratin
and negative for CD45, excluding contaminating Jurkat
cells. Microsatellite analysis of the sorted BrdU1 pop-
ulation revealed bands specific for both Jurkat and
HaCaT cells, whereas the BrdU-negative sorted popu-
lation revealed only HaCaT-specific microsatellite
bands (Figure 4). In addition, FISH analysis showed
that 0.8% of the BrdU1 sorted cells were Y1/
cytokeratine1, whereas all BrdU2 cells were Y2/
cytokeratine1. We asked whether HaCaT cells that
have internalized the foreign DNA remain viable. The
BrdU1 sorted fraction contained more Annexin1 cells
(25%) compared to the BrdU2 sorted cells (14%)
(Figure 4). We placed BrdU1 cells in culture and con-
firmed by CFSE proliferation assay that the cells are
able to proliferate. After 1 week in culture, BrdU1
sorted cells reached similar confluency as the BrdU2fraction (Figure 4). However, no BrdU or Y signal
was any more detectable in the BrdU1 sorted popula-
tion after 1 week culture, suggesting that the foreign
material is either removed from the host genome or
not replicated and diluted among subsequent cell
divisions.Donor-Derived DNA in Buccal Swabs after
Allogeneic HCT
It is unclear whether such a horizontal DNA trans-
fer, as shown in our in vitro model, takes place also in
vivo after human allogeneic transplantation. We hy-
pothesized that if such a molecule trafficking between
cells happens after clinical transplantation, then we
would expect to detect donor DNA in epithelial tis-
sues. In an elegant study, Imanishi et al. [21] found
by quantitative microsatellite analysis a large amount
of donor DNA in fingernails of transplant recipients.
We therefore evaluated the amount of donor in 176
buccal swabs obtained from 71 patients after alloge-
neic transplantation. Attention has been paid to ex-
clude hematopoietic cell contamination as the source
of donor DNA. All samples were taken when the pa-
tients had no signs of oral GVHD or mucositis. Inter-
estingly, we found a high amount of donor DNA in
nearly all patients (Figure 5). Sixty-one out of 68 evalu-
able patients (89.7%) revealed donor-derived microsa-
tellite peaks even a long period after transplantation
(median 324 days, 30-3683 days), and the mean per-
centage of donor peak areas was 26.6% (range:
2.3%-82.1%). Although contamination with donor-
derived hematopoietic cells cannot be convincingly ex-
cluded, we found no indication that this uniform and
extensive donor-type chimerism in buccal samples
could be solely explained by the presence of graft-
derived hematopoietic cells in the buccal swabs. The
mean number of CD451 cells in parallel cytospins
Figure 5. Donor-derived DNA in buccal swabs after allogeneic HCT. Capillary electrophoresis of PCR for microsatellite markers. Large amount
of donor-DNA was detected in buccal samples after transplantation. Two representative examples are shown (A and B). P/D: patient/donor-specific
microsatellite peaks; d: day of sampling after transplantation.
326 Biol Blood Marrow Transplant 17:319-329, 2011M. Waterhouse et al.from the buccal samples was 0 out of mean 460 cells
evaluated (range: 0%-0.7%). Furthermore, we specifi-
cally analyzed more precisely 22 buccal samples with
high percentage of donor-DNA (range: 4%-82.1%)
for the presence of hematopoietic cells both by
immunocytochemistry and by FACS. Again, no signif-
icant percentage of CD45, CD3, CD15, CD68, or
Langerin expressing cells were detected (Figure S2
and Table S1).DISCUSSION
Distinct epithelial cells containing donor-derived
genome have been previously detected in animal
models and in humans after allo-HCT by in situ detec-
tion of Y-chromosome in female recipients [3-7]. In
the above-mentioned studies, Y-chromosome positive
cells were always found as single cells and not as clus-
ters. If these cells were generated from a universal type
of stem cell, like ‘‘multipotent adult progenitor cell’’[9] or ‘‘very small embryonic like cell’’ (VSEL) [22]
or spontaneously in vivo induced pluripotent stem
cells [10], one would expect large clones of Y1 cells
to be detected. Fusion between donor hematopoietic
cells and recipient cells has been also suggested as
a mechanism explaining the emergence of donor-
derived epithelial cells [23,24]. On the other hand,
several reports using Cre/lox technology [25] or chro-
mosome analysis [5] suggest that nonfusion mecha-
nisms may be also implicated in the generation of
epithelial chimerism. More recent findings suggest
molecule trafficking as a novel mechanism explaining
the detection of epithelial cells with donor genome af-
ter allo-HCT. Jang et al. [26] found that when murine
hematopoietic stem cells are cocultured with injured
liver separated by a barrier, they may convert into
liver-like cells. Aliotta et al. [27] and Ratajczak et al.
[28] showed that this phenotypical conversion may
be because of mRNA transfer between cells, resulting
in an aberrant expression of foreign proteins in the
Figure 6. Horizontal DNA transfer from donor to host cells as an alternative new mechanism of epithelial chimerism after allogeneic hematopoietic
cell transplantation. Our proposed model suggests that after allo-HCT, there is a continuous transfer and integration of donor apoptotic genomic ma-
terial into host epithelium that results in emergence of epithelial cells that contain donor-derived genome.
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mRNA transfer from epithelial to hematopoietic cells
cannot explain recent findings after clinical transplan-
tation, such as the detection of a large amount of
donor-DNA in blood-free fingernails [21] obtained
from transplanted recipients or the absence of hemato-
poietic marker expression in the Y-chromosome posi-
tive epithelial-like cells found in female allotransplant
recipients.
Here, we propose horizontal DNA transference as
an alternative explanation for epithelial chimerism
after hematopoietic stem cell transplantation. In an
in vitro coculture system, we showed that DNA can
be horizontally transferred from hematopoietic cells
to epithelial cell lines and primary bone marrow stro-
mal cells as well. In line with Holmgren et al. [29], we
demonstrate that the uptake of foreign DNA was ac-
complished through an active phagocytotic process
of apoptotic bodies and not fusion of intact cells or
transfer of free DNA. However, because induction of
apoptosis in Jurkat cells in our system was not 100%,
we cannot formally exclude the possibility that apopto-
tic signaling enabled and was required for fusion
between intact Jurkat cells and HaCaT cells. Most in-
terestingly, and in accordance with a previous study of
Bergsmedh et al. [30], we found ingested apoptotic ge-
nomic material within the nuclear compartment and in
isolated chromosomes obtained from HaCaT meta-
phases. Whether the intranuclear transferred DNA is
integrated within the genome or remains episomal is
still uncertain. Nevertheless, we have not observed
extrachromosomal labeled genetic material in themetaphase spreads. It is interesting to note that the
difference of DNA transfer in our in vitro system
when estimated as BrdU1 cells (up to 16%) compared
to Y1 cells (up to 3%), reflects the difference in the
estimated extent of buccal mixed chimerism detected
by PCR-based microsatellite analysis (26.6%) and in
situ FISH for Y chromosome (2.9%) [5]. Whether
the entry of DNA into recipient cells is regulated by
the fragment size or type of DNA fragmentation is un-
der consideration [31]. Even whole chromosomes have
been reported to be transferred byHGT [30]. The size
of the nuclear pore complex makes it quite unlikely
that a fragment such as part or the whole Y chromo-
some can cross the nuclear envelope; however, during
mitosis the nuclear envelope transiently disappears
[32]. Interestingly, when we blocked HaCaT cell
cycle by aphidicolin prior to cocultivation with
Jurkat apoptotic bodies, no Y chromosome signal
could be detected (data not shown). In addition, the
Y chromosome signal was detected during different
stages of HaCaT cell division (Figure 3A), indicating
that part or the whole Y chromosome is incorporated
in the absence of the nuclear envelope. Taking these
observations together, it seems that an active cell cycle
is needed in order to incorporate large pieces of
foreign DNA.
In our in vitro system, the horizontal transfer of
DNA declined over time, which seems contradictory
to the in vivo observation of the detection of a low per-
centage of epithelial cells containing donor-derived
genome also many years after transplantation [5,6].
However, coculture in our system was short time,
328 Biol Blood Marrow Transplant 17:319-329, 2011M. Waterhouse et al.unlike the in vivo situation after allo-HCTwhere there
is a continuous and long-term release of a large
amount of donor-derived genomic material from the
engrafted bone marrow. In line with that, foreign
DNA uptake and intranuclear transfer in HaCaT
cells was increased when these were repetitively ex-
posed to apoptotic bodies. Normally, internalized
foreign material is degradated in the cytoplasm by
lysosomes [13,33]. Both lysosomal inhibition in
HaCaT cells and augmented charge of HaCaT cells
with apoptotic bodies increased the horizontal
intercellular and intranuclear DNA delivery. In the
context of allo-HCT where there is an incessant
charge of epithelium with donor-DNA, which may re-
sult in saturation of lysosomal activity, HGT may be
indeed operative.We are not aware of any data demon-
strating HGT in humans. Nevertheless, horizontal
transfer of genetic material has been described to occur
in vivo in a mouse model where fragments of food-
derived ingested DNA were ultimately detected in
peripheral white blood cells, spleen, and liver [34].
Recently, Ehnfors et al. provided direct evidence that
tumor DNA may be horizontally transferred to vascu-
lar endothelial cells in an vivo animal model [35].
Although recipient cells remained viable and
showed to express the foreign DNA, this expression
was transient, and the transferred DNA was lost
upon 1 week in culture. In line with us, Holmgren
et al. [29] have shown that cultivation of apoptotic bod-
ies derived from Epstein-Barr virus (EBV)-carrying
cell lines with either fibroblasts or endothelial cells re-
sulted in the uptake of DNA and expression of EBV-
specific markers in proteins in as many as 20% of the
recipient cells and up to 5 weeks. It can be speculated
that internalized transferred DNA is identified by the
cell as damaged DNA resulting in activation of DNA
repair machinery and removal of the foreign DNA. In-
deed, if the p53-p21 DNA repair pathway is inacti-
vated in the recipient cell, then the horizontally
transferred DNA may be propagated and, provided
that confers a selective advantage to the cell, may be
also permanently expressed. In an elegant study,
Bergsmedh et al. demonstrated that oncogenes
(c-myc and H-rasV12) horizontally transferred by the
uptake of apoptotic bodies in p53-negative recipient
cells may be replicated and expressed leading to loss
of contact inhibition and anchorage independence in
vitro and development of a tumorigenic phenotype in
vivo [30]. Relevant to that might be our and others ob-
servation that posttransplantation tumors carry p53
mutations or alterations [28]. Recently, Janin et al.
[36] examined 8 oral squamous cell carcinomas after
allogeneic bone marrow transplantation and found in
4 of them a large amount of donor-DNA. The authors
suggested that these tumors arose from fusion of mar-
row cells to cancer stem cells or alternatively from
transformed donor-derived mesenchymal stem cellsthat were coinfused with the marrow graft. Vertical
propagation of horizontally transferred donor-DNA
in the p53 mutated cancer cells confers an alternative
explanation of the donor ‘‘origin’’ of secondary tumors
after allogeneic transplantation.
Our in vivo results revealed the presence of high
amount of donor-derived genomic material in the
buccal epithelium of the majority of allo-
transplanted patients, which was detected even a
long period after allo-HCT. Our results are in line
with recently published studies detecting substantial
amounts of donor DNA (median 63%, 10%-96%) in
buccal samples [37]. The most plausible explanation
for the presence of mixed chimerism in buccal swabs
after allogeneic HCT is the presence of donor-
derived hematopoietic cells. However, in accordance
with others [38], no CD451 or Langerhan’s cells
were detected in the buccal swabs, and therefore it
seems unlikely that this high and constant contribu-
tion of donor-DNA into host epithelium is attributed
solely to contamination with donor hematopoietic
cells in the buccal swabs. However, we cannot rule
out the possibility that extracellular DNA from hema-
topoietic cells in the buccal smears is the source of the
detected donor microsatellite peaks. Interestingly,
more recently. Imanishi et al. [21] reported the pres-
ence of high amount of donor-DNA (8.9%-72.9%)
in blood-free fingernails up to 21.5 years after trans-
plantation. In the latter study, the authors suggested
that the detection of donor DNA in fingernails was be-
cause of emergence of donor-derived nail stem cells.
Here, we propose that the substantial amount of
donor-DNA found in buccal cells (this study and
[37]) or fingernails [21] after allogeneic HCT could
be explained by the uptake of hematopoietic donor-
DNA by host epithelial cells.
Taken together, our in vivo and in vitro data may
support the following scenario after allo-HCT
(Figure 6): the engrafted bone marrow produces
continuously hematopoietic cells that after their pro-
grammed death charge constantly the host environ-
ment with donor-derived apoptotic bodies. In this
context, the excessive (especially in GVHD lesions)
amount of foreign material taken up repetitively by
the recipient’s professional and nonprofessional
phagocytic cells may overwhelm their lysosomal
capacity, and thus, part of the donor-derived apoptotic
DNA fragments may escape degradation in the cyto-
plasm and be transferred into the nucleus. This inces-
sant ‘‘inappropriate’’ intranuclear delivery of donor
DNA in epithelial cells after allogeneic HCT may
come in light of detection of epithelial cells contain-
ing donor-derived genome. Although this hypothesis
is difficult to verify in human beings, this model may
provide a new resource for understanding unresolved
pathomechanisms of unique clinical manifestations
after allo-HCT.
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